Ethical, scientific and translational limitations of animal testing have increased the global pursuit of high quality, human relevant, biomedical research, toxicological, and drug development alternatives. The combination of artificial intelligence (AI) and cell-based assays, organ-on-chip (OoC) technologies, and computational modelling, is transforming the paradigm of experimental research by promoting predictive, scalable, and ethically responsible research. The chapter gives a general but inclusionary review of AI-based substitutes of animal testing in reference to three pillars of change, including advanced cell-based systems, micro physiological organ-on-chip technology, and AI-enabled virtual bodies (in silico models).The chapter starts with the analysis of the historical dependence on animal models, regulatory/ethical forces behind replacing, minimizing, and refining (3Rs).